Stockreport

Protara Highlights Recent Updates and Anticipated 2025 Milestones

Protara Therapeutics, Inc.  (TARA) 
PDF Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC Completed approximately $100 million public offering, extending runway into 20 [Read more]